Sivia Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
+2,180
New +$1.05M 0.13% 180
2025
Q4
Sell
-493
Closed -$239K 592
2025
Q3
$239K Buy
+493
New +$229K 0.07% 400
2025
Q2
Sell
-891
Closed -$443K 461
2025
Q1
$443K Buy
891
+158
+22% +$85.6K 0.21% 85
2024
Q4
$381K Buy
733
+77
+12% +$42.3K 0.19% 82
2024
Q3
$406K Buy
656
+35
+6% +$20.7K 0.24% 79
2024
Q2
$343K Sell
621
-13
-2% -$7.45K 0.23% 84
2024
Q1
$368K Buy
634
+140
+28% +$78.6K 0.25% 78
2023
Q4
$262K Buy
+494
New +$239K 0.2% 118

Other funds holding TMO

Sivia Capital Partners's TMO Position: Q2 2026 in Review

Sivia Capital Partners opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 2,180 shares worth $1.09M. The stake represents 0.13% of the portfolio and ranks #180 among its holdings. This is a return to the name: Sivia Capital Partners previously reported a position in TMO as recently as Q3 2025.

Sivia Capital Partners first reported a position in TMO in Q4 2023 and has held it in 8 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sivia Capital Partners held 2,180 shares of Thermo Fisher Scientific worth $1.09M as of Q2 2026.
  • Thermo Fisher Scientific was a new Sivia Capital Partners position in Q2 2026.
  • Thermo Fisher Scientific made up 0.13% of Sivia Capital Partners's portfolio in Q2 2026, its #180 holding.
  • Sivia Capital Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 8 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.